
KEMIMEDI CEO Choi Gun-sub, fourth from left, poses with SK Securities CEO Kim Shin, left, and other bourse officials to celebrate the drug developer’s listing on the country’s third stock market of the Korea New Exchange (KONEX) at the Korea Exchange office in Seoul, Friday. SK Securities advised the firm on its entry into the KONEX. / Yonhap